Caden Capital Partners’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$255K Sell
641
-750
-54% -$214K 3.07% 10
2026
Q1
$241K Buy
1,391
+954
+218% +$196K 2.97% 12
2025
Q4
$112K Buy
+437
New +$115K 0.25% 7
2024
Q4
Sell
-108,524
Closed -$34.4M 12
2024
Q3
$34.4M Buy
108,524
+71,844
+196% +$25.6M 11.59% 4
2024
Q2
$13.7M Sell
36,680
-5,813
-14% -$1.96M 4.96% 11
2024
Q1
$14.7M Buy
42,493
+15,775
+59% +$5.98M 5.41% 9
2023
Q4
$12.2M Buy
+26,718
New +$13.2M 4.45% 11

Other funds holding HUM

Caden Capital Partners's HUM Position: Q2 2026 in Review

Caden Capital Partners reduced its Humana (HUM) stake by 54% in Q2 2026, selling an estimated $214K and leaving 641 shares worth $255K. The position accounts for 3.07% of the portfolio, ranked #10.

Caden Capital Partners first reported a position in HUM in Q4 2023 and has held it in 7 quarters since. The position peaked at $34.4M in Q3 2024. 919 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Caden Capital Partners held 641 shares of Humana worth $255K as of Q2 2026.
  • Caden Capital Partners sold 750 Humana shares in Q2 2026, an estimated $214K.
  • Humana made up 3.07% of Caden Capital Partners's portfolio in Q2 2026, its #10 holding.
  • Caden Capital Partners first reported a position in Humana in Q4 2023 and has held it in 7 quarters since.
  • Caden Capital Partners's Humana position peaked at $34.4M in Q3 2024.
  • 919 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Caden Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.